SCHEMBL10133340

SCHEMBL10133340

N#CCOc1cccc(NC=O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.46
HTT P42858 1/20 0.46
ALDH1A1 P00352 5/20 0.41
FFAR1 O14842 1/20 0.41
GMPS P49915 1/20 0.37
KDM4E B2RXH2 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
ALDH2 P05091 1/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
TSHR P16473 1/20 0.36
SYK P43405 3/20 0.36
CTSA P10619 1/20 0.36
MAPK1 P28482 3/20 0.35
CDC7 O00311 1/20 0.35
PLK4 O00444 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1187511 0.80 HTT (0.55) HSD17B10HTTALDH1A1KDM4ESMN1; SMN2
SCHEMBL24861212 0.80 ALDH1A1 (0.44) HSD17B10HTTALDH1A1SMN1; SMN2MEN1
SCHEMBL12882290 0.80 ALDH1A1 (0.44) HSD17B10HTTALDH1A1KDM4ESMN1; SMN2
SCHEMBL10683066 0.79 ALDH1A1 (0.52) HTTALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL509575 0.78 FFAR1 (0.48) HSD17B10HTTALDH1A1FFAR1KDM4E
SCHEMBL10387919 0.77 KMT2A (0.54) ALDH1A1SMN1; SMN2GAAMEN1KMT2A
SCHEMBL10133726 0.77 ALDH1A1 (0.41) HSD17B10HTTALDH1A1SMN1; SMN2HPGD
SCHEMBL10676597 0.77 PRSS1 (0.53) HTTALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL5201274 0.77 DRD2 (0.54) HSD17B10HTTALDH1A1SMN1; SMN2HPGD
SCHEMBL3064450 0.77 SMN1; SMN2 (0.60) HSD17B10HTTALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292500-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R HSD17B10 1102/4885HTT 1904/4885ALDH1A1 4599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.